HGH Fragment 176-191 2 mg
A growth-hormone-derived peptide segment.
CAD $35.00 / vial
Vial amount
The specifics, clearly listed.
Product details
Product reference: MRD-0077 Listed amount per vial: 2 mg Sales unit: 1 vial
Read the research in context.
A growth-hormone-derived peptide segment.
- Human Growth Hormone Fragment 176–191 Peptide Enhances the Toxicity of Doxorubicin-Loaded Chitosan Nanoparticles Against MCF-7 Breast Cancer Cells — source
Candidate-molecule or reference-product background; not verification of this supplied product.
What this doesn’t establish: Do not equate native 176–191, 177–191 and modified AOD9604. Supplier sequence, N-terminal residue, disulfide pattern and terminal chemistry are needed. The 2022 paper itself describes a terminal-residue substitution in its background; its title alone must not be treated as proof of a native-fragment identity. Exact supplied identity/form, measured amount, lot-linked quality reports, purity, sterility/endotoxin, storage/stability and authorization are not established by these references.
Product documents
No verified report is available here for this item. Ask about documentation for HGH Fragment 176-191, product reference MRD-0077.
Before you decide.
Separate research about the compound from evidence about the supplied product.
Which vial amount is shown?
This listing shows 2 mg per vial.
Does the study verify this vial?
No. Research on a compound does not establish the identity, quality, safety or effectiveness of a product sold under that name.
What should I check in a report?
Check the sample identity, batch reference, issuer, date, test methods and results. A report applies to the identified sample and tests.
What information should I request?
Ask about the exact product identity, form, specification, handling requirements and relevant batch documents before deciding.